Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Heart failure or sudden cardiac death seemed the most likely cause of death in the control group, because pulmonary edema was evident but cerebral infarction/hemorrhage or myocardial infarction were not observed at autopsy.Results of clinical tests performed on Day 0 and Day 14.ParametersControl (N = 8)Treatment (N = 8)Control vs. treatment on day 14Day 0Day 14Day 0Day 14PSystolic blood pressure (mmHg)111 ± 22109 ± 32137 ± 21130 ± 240.170Diastolic blood pressure (mmHg)83 ± 1859* ± 2395 ± 2181 ± 210.072Pulse pressure(mmHg)28 ± 1350** ± 1242 ± 1449 ± 130.896Heart rate(beats/min)122 ± 27138 ± 20105 ± 13109 ± 350.059pH7.465 ± 0.0607.390* ± 0.0517.502 ± 0.0497.380** ± 0.0290.653pCO2 (mmHg)45.6 ± 7.432.9** ± 2.941.0 ± 8.433.6* ± 3.20.682pO2 (mmHg)87.4 ± 13.278.3 ± 8.885.3 ± 11.390.8 ± 14.40.055Base excess (mmol/L)8.6 ± 2.2 − 4.8** ± 4.38.6 ± 3.5 − 5.1** ± 2.50.835Bicarbonate (mmol/L)32.5 ± 2.220.2** ± 3.531.7 ± 3.819.9** ± 2.30.863Urea nitrogen(mg/dL)6.9 ± 1.991.8** ± 18.87.6 ± 2.2102.6** ± 29.70.402Creatinine (mg/dL)0.9 ± 0.111.7** ± 1.60.9 ± 0.19.3** ± 1.20.005Potassium (mmol/L)3.6 ± 0.25.8** ± 0.73.8 ± 0.26.6** ± 0.80.084Calcium (mg/dL)11.0 ± 0.411.1 ± 1.010.7 ± 0.412.0** ± 1.00.108Phosphorus (mg/dL)5.9 ± 0.516.0** ± 6.25.5 ± 0.711.4** ± 2.40.070Calcium phosphorus product (mg2/dL2)65.5 ± 7.8173.7** ± 54.458.2 ± 7.1135.1** ± 27.20.094Magnesium (mg/dL)1.90 ± 0.082.03 ± 0.302.00 ± 0.292.38 ± 0.190.0581,25-dihydroxy Vitamin D3 (pg/mL)643 ± 21066** ± 18896 ± 34581** ± 280.213Whole parathyroid Hormone (pg/mL)4.1 ± 3.892.9** ± 61.67.8 ± 8.460.1** ± 21.80.178Kt/VN.A1.92 ± 0.40N.A2.09 ± 0.920.640The data indicate mean ± s.d.*P < 0.05 and **P < 0.01 vs .Day 0 by Student’s t-test.

Source: Survival. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Laboratory / cell research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

CPPs were generated in vitro by increasing the calcium and phosphate concentration to 5 mM and 7 mM, respectively, in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and incubating at 37 °C for 24 h.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Removal of calciprotein particles from the blood using an adsorption column improves prognosis of hemodialysis miniature pigs

Study design awaiting verification · Scientific Reports · 2023

Original publication title

Removal of calciprotein particles from the blood using an adsorption column improves prognosis of hemodialysis miniature pigs

Marina Miura; Yutaka Miura; Yoshitaka Iwazu; Hideyuki Mukai; Takahiro Sugiura; Yuji Suzuki; Masami Kato; Mayumi Kano; Daisuke Nagata; Kazuhiro Shiizaki; Hiroshi Kurosu; Makoto Kuro-o

© The Author(s) 2023

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Hyperphosphatemia is a major risk for poor prognosis in patients with end-stage renal disease. However, the molecular mechanism behind this link remains elusive. We and others have demonstrated that serum phosphorus levels correlate positively with circulating levels of calciprotein particles (CPPs). CPPs are colloidal mineral-protein complexes containing insoluble calcium-phosphate precipitates and have been reported to induce calcification in cultured vascular smooth muscle cells and inflammatory responses in cultured macrophages. Hence, we hypothesize that CPPs may be responsible for disorders associated with hyperphosphatemia.

Using hyperphosphatemic miniature pigs receiving hemodialysis, here we show that removal of CPPs from the blood with a newly developed CPP adsorption column improves survival and alleviates complications including coronary artery calcification, vascular endothelial dysfunction, metastatic pulmonary calcification, left ventricular hypertrophy, and chronic inflammation. The present study identifies CPPs as an effective therapeutic target and justifies clinical trials to determine whether the CPP adsorption column may be useful as a medical device for improving clinical outcomes of hemodialysis patients.

Authors’ abstract

Hyperphosphatemia is a major risk for poor prognosis in patients with end-stage renal disease. However, the molecular mechanism behind this link remains elusive. We and others have demonstrated that serum phosphorus levels correlate positively with circulating levels of calciprotein particles (CPPs). CPPs are colloidal mineral-protein complexes containing insoluble calcium-phosphate precipitates and have been reported to induce calcification in cultured vascular smooth muscle cells and inflammatory responses in cultured macrophages. Hence, we hypothesize that CPPs may be responsible for disorders associated with hyperphosphatemia.

Using hyperphosphatemic miniature pigs receiving hemodialysis, here we show that removal of CPPs from the blood with a newly developed CPP adsorption column improves survival and alleviates complications including coronary artery calcification, vascular endothelial dysfunction, metastatic pulmonary calcification, left ventricular hypertrophy, and chronic inflammation. The present study identifies CPPs as an effective therapeutic target and justifies clinical trials to determine whether the CPP adsorption column may be useful as a medical device for improving clinical outcomes of hemodialysis patients.

Publication and source details

Original title: Removal of calciprotein particles from the blood using an adsorption column improves prognosis of hemodialysis miniature pigs

Marina Miura; Yutaka Miura; Yoshitaka Iwazu; Hideyuki Mukai; Takahiro Sugiura; Yuji Suzuki; Masami Kato; Mayumi Kano; Daisuke Nagata; Kazuhiro Shiizaki; Hiroshi Kurosu; Makoto Kuro-o

Scientific Reports · 2023

© The Author(s) 2023https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.AMED-CRESTJP19gm0610012Kuro-o Makoto AMED-ACT-MSJP81im0210806Kuro-o Makoto AMED-ACT-MJP22im0210225Kuro-o Makoto http://dx.doi.org/10.13039/501100001691Japan Society for the Promotion of ScienceJP16H05302Kuro-o Makoto

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T16:27:48.514418+00:00

DOI: 10.1038/s41598-023-42273-0 · PMC10497634